Suchergebnisse - (Standardsuche:issn:"1568-0096" OR issn:"1873-5576")

PubPharm (35)

1

Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer

enthalten in: Current cancer drug targets | 2018

von Sanchala, D. | Bhatt, L. | Prabhavalkar, K.

2

A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastoma

enthalten in: Current cancer drug targets | 2017

von Kwatra, M.

3

EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo

enthalten in: Current cancer drug targets | 2017

von Zhou, C. | Zhu, L. | Ji, J. | +6

4

Insight into Discovery of Next Generation Reversible TMLR Inhibitors Targeting EGFR Activating and Drug Resistant T790M Mutants

enthalten in: Current cancer drug targets | 2017

von Agarwal, S. | Pal, D. | Gupta, M. | +1

5

Role of EGFR Monoclonal Antibodies in the Management of Non-small Cell Lung Cancer

enthalten in: Current cancer drug targets | 2015

von Takeda, M. | Nakagawa, K.

6

Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer

enthalten in: Current cancer drug targets | 2015

von Subramaniam, D. | He, A. | Hwang, J. | +4

7

Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM

enthalten in: Current cancer drug targets | 2015

von Yang, Z. | Liu, Y. | Wei, X. | +7

8

Cetuximab inhibits gastric cancer growth in vivo, independent of KRAS status

enthalten in: Current cancer drug targets | 2014

von Shi, M. | Shi, H. | Ji, J. | +6

9

Roles of EGFR, PI3K, AKT, and mTOR in heavy metal-induced cancer

enthalten in: Current cancer drug targets | 2013

von Carpenter, R. | Jiang, B.

10

Two novel GPER agonists induce gene expression changes and growth effects in cancer cells

enthalten in: Current cancer drug targets | 2012

von Lappano, R. | Rosano, C. | Santolla, M. | +7